Next-Generation Technologies in Infectious Diseases: From AI to Smart Diagnostics and Beyond
- Artificial Intelligence & Machine Learning
- Next-Generation Diagnostics & Point-of-Care Technologies
- Genomics, Proteomics & Multi-Omics
- Nanotechnology & Advanced Therapeutics
- Digital Health & Telemedicine
- Robotics & Automation in Laboratories
- Global Preparedness
The field of infectious diseases is entering a transformative era driven by technological innovation. Traditional approaches to detection, treatment, and surveillance are being rapidly complemented—and in many cases, redefined—by advanced tools that are reshaping the global response to infectious threats. This session explores how next-generation technologies are revolutionizing the way we predict, diagnose, and manage infections, while also laying the groundwork for future preparedness.
Artificial intelligence and machine learning are already enhancing outbreak prediction, accelerating vaccine and drug discovery, and enabling smarter decision-making in clinical practice. Smart diagnostics, including CRISPR-based assays, microfluidic lab-on-chip platforms, and wearable biosensors, are allowing clinicians to identify pathogens with unprecedented speed and accuracy—even in low-resource settings. Similarly, next-generation sequencing and multi-omics approaches are unlocking new insights into host–pathogen interactions, antimicrobial resistance, and personalized medicine. Beyond diagnostics, innovations in nanotechnology, robotics, and automation are optimizing infection control, improving drug delivery systems, and supporting laboratory workflows at scale. Digital health platforms and mobile technologies are expanding real-time disease surveillance and providing equitable access to care in underserved regions, ensuring that technological progress benefits global communities. Looking forward, the integration of bioconvergence—where biology, engineering, and digital technologies merge—will further expand possibilities. From developing digital twins for infection modeling to advancing regenerative therapies, the future holds significant potential for addressing persistent and emerging infectious challenges.
This session will bring together experts across disciplines to share breakthroughs, case studies, and visions for the future. Attendees will gain valuable insights into how technological innovations are not only reshaping infectious disease management today but also setting the stage for a safer, more prepared tomorrow.
